Clinical trials are underway to study GLP-1 medications for things like heart failure, smoking cessation, alcohol use disorder, nonalcoholic fatty liver disease, and even neurodegenerative conditions like Alzheimers
Psychiatric adverse events happen at similar or even slightly lower rates in people taking GLP-1 medications compared to placebo
We always strive to get insurance coverage for our patients, and we accept all major PPO insurance plans
Medical History Failure to fully disclose your medical history to your provider may result in serious side effects, includingdeath
Problem: no noticeable effects after 4 weeks at 2mg This is actually normal
Key Research Attributes Highly innovative triple-agonist activity: GLP-1, GIP, and glucagon receptors